November 25, 2013

VIDEO: OLYSIO™ (simeprevir) receives US FDA approval

63793-Janssen-Consumer-original

Provided by Janssen

Novenber 22, 2013

OLYSIO™(simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C

OLYSIO™ is the first once-daily protease inhibitor approved for the treatment of chronic hepatitis C in a combination antiviral regimen for adults with compensated liver disease.

See Press Release here 

0 comments :

Post a Comment